INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
MR

Moat Ross

CHIEF OPERATING OFFICERCIK 0001857177

EDGAR filingsOpen in network
Disclosed transactions34
Buys / sells0 / 13
Max Insider Score19
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
9,412 sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Kiniksa Pharmaceuticals International, plcCHIEF OPERATING OFFICER · Apr 8, 2026
0
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M
$45K
3,760 sh
Oct 30, 2026
Nov 3, 2026
traded Oct 30, 2026
+4d
SEC FORM 4

Evidence

15
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$353K
3,672 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

8
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$171K
1,760 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

5
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$68K
722 sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

0
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
16.1K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

0
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
21.1K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

0
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
3,760 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

7
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
10.9K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

10
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M$268K
12.3K sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

0
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M$143K
6,263 sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

4
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
12.3K sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

0
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
6,263 sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

10
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M$173K
16.1K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

2
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M$197K
10.9K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

15
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$792K
8,430 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

15
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$596K
6,282 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

15
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$252K
2,575 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

7
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M$170K
9,412 sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

0
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
1,658 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

0
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
16.1K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

9
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M$286K
16.1K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

10
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M$234K
21.1K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

0
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M$22K
1,658 sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

18
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$3.48M
37.8K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

18
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$1.40M
15.1K sh
Oct 30, 2026Nov 3, 2026
traded Oct 30, 2026
+4dSEC FORM 4

Evidence

8
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$610K
6,681 sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

12
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$822K
8,932 sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

19
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$1.08M
11.6K sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

8
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$80K
1,703 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC FORM 4

Evidence

12
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$115K
2,367 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC FORM 4

Evidence

3
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
2,477 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC FORM 4

Evidence

0
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Tax withholding · 10b5-1 plan
F$38K
774 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC FORM 4

Evidence

0
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
2,477 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC FORM 4

Evidence